Log In
BCIQ
Print this Print this
 

Biosimilar denosumab (ONS-4010)

  Manage Alerts
Collapse Summary General Information
Company Oncobiologics Inc.
Description Biosimilar of denosumab, a human mAb targeting receptor activator of NF-kappa B ligand (RANKL; TNFSF11)
Molecular Target Receptor activator of NF-kappa B ligand (RANKL) (TNFSF11)
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis in postmenopausal women
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today